Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA
Clinical trial NCT06896136 · COMPLETED
Trial details
- NCT number
- NCT06896136
- Sponsor
- Mark Klempner
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2025-05-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.